The Amnestic Disorders Therapeutics market was valued at USD 3,372.00 Million in 2022 and is expected to reach USD 6,521.00 Million by 2030, growing at a CAGR of 4.2% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.